VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $163,000 | +16.4% | 10,000 | 0.0% | 0.10% | +9.7% |
| Q4 2020 | $140,000 | +38.6% | 10,000 | 0.0% | 0.09% | +19.2% |
| Q3 2020 | $101,000 | -12.2% | 10,000 | 0.0% | 0.08% | -19.6% |
| Q2 2020 | $115,000 | +11.7% | 10,000 | 0.0% | 0.10% | -5.8% |
| Q1 2020 | $103,000 | -36.4% | 10,000 | 0.0% | 0.10% | -3.7% |
| Q4 2019 | $162,000 | +21.8% | 10,000 | 0.0% | 0.11% | +10.3% |
| Q3 2019 | $133,000 | – | 10,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Profit Investment Management, LLC | 326,997 | $1,412,627 | 1.00% |
| Stonepine Capital Management, LLC | 477,903 | $2,064,541 | 0.69% |
| Krensavage Asset Management, LLC | 360,429 | $1,557 | 0.57% |
| Nantahala Capital Management | 1,000,000 | $4,320,000 | 0.37% |
| Monaco Asset Management SAM | 135,000 | $583,200 | 0.17% |
| CTC Alternative Strategies, Ltd. | 18,400 | $79,488 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 406,019 | $1,754 | 0.15% |
| Sio Capital Management, LLC | 97,616 | $421,701 | 0.13% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 156,000 | $673,920 | 0.13% |
| Virtus ETF Advisers LLC | 48,530 | $209,650 | 0.13% |